Sungcalang, Gloria T.
HRN: 27-79-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2025
CEFTRIAXONE 1G (VIAL)
09/13/2025
09/20/2025
IVTT
2g
Od
Infected Breast Mass
Checking Initial Appropriateness
09/13/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/13/2025
09/27/2025
IVTT
600mg
Q6
Infected Breast Mass
Checking Initial Appropriateness